Unique Physique is collaborating with pharmacies to assess current Tirzepatide supply, ensuring a smooth transition for our patients. While the FDA has removed it from the shortage list, insurance approval is not guaranteed. We remain committed to supporting all patients and may transition some to Semaglutide if necessary to maintain effective treatment.